Latest Industry News & Trends

Recently Added

9/20/2019
BreakingIOLOphthalmic
J&J Vision Launches TECNIS Synergy IOL in Europe, Australia, and New Zealand

Johnson & Johnson Vision launched its TECNIS Synergy intraocular lens on Sept. 16 in Paris. The IOL is available in Europe, Australia, and New Zealand. The company describes the Synergy as a presby...

9/20/2019
BreakingIOLOphthalmic
BVI’s PhysIOL Launches FineVision Triumf EDOF Trifocal IOL

Beaver-Visitec International announced Sept. 12 that its PhysIOL subsidiary launched the FineVision Triumf trifocal extended depth of focus (EDOF) IOL in Europe in conjunction with the 2019 Congres...

9/20/2019
BreakingLaserOphthalmicSurgical
Alcon Launches Two Enhancements to WaveLight Refractive Suite

Alcon announced Sept. 9 that it has launched two additions to its WaveLight Refractive Suite for LASIK surgery: complementary diagnostic software intended to provide the most enhanced corneal profi...

9/20/2019
BreakingGene TherapyOphthalmicRetinal
Adverum Reports Positive Results from First Cohort in Phase I Trial of Gene Therapy to Treat Wet AMD

Adverum Biotechnologies announced on Sept. 11 positive 24-week clinical data from the first cohort of six patients treated with a one-time intravitreal (IVT) dose of ADVM-022 in the company’s Phase...

9/20/2019
BreakingDry EyeFundingOphthalmic
Aurinia Looks to Raise $40 Million with ‘At the Market’ Offerings

Aurinia Pharmaceuticals announced Sept. 13 that it would sell, through periodic “at the market” (ATM) offerings, common shares with an aggregate offer price of up to $40 million. Aurinia said it in...

9/20/2019
BreakingCornealDeviceOphthalmic
CorNeat Vision Completes Preclinical Phase for Synthetic Cornea and Scleral Patch

CorNeat Vision, of Israel, announced Sept. 9 that it had completed the preclinical stage for its investigational corneal implant and synthetic, nondegradable scleral patch. The company’s product ca...

9/20/2019
BreakingFundingOphthalmicRetinal
Lineage Cell Therapeutics Sells OnoCyte Shares, Raises $6.6 Million

Lineage Cell Therapeutics announced Sept. 11 that it had sold 4 million shares of common stock of OncoCyte at $1.66 per share. Gross proceeds from the sale were $6.6 million. The Carlsbad, Californ...

9/20/2019
BreakingIOLOphthalmicSurgical
MST Innovations Introduces the Scleral IOL Fixation Solutions Pack

MicroSurgical Technology has introduced its Scleral IOL Fixation Solutions Pack, designed to streamline the double-needle scleral IOL fixation technique with new instruments packaged together to su...

9/20/2019
BreakingClinical TrialOphthalmicPharma
Nevakar Completes Enrollment in Phase III Study of Drug Candidate to Slow Myopia in Children

Nevakar announced Sept. 11 that it had completed enrollment in a Phase III study evaluating the ability of its candidate NVK-002 to slow the progression of myopia in children. NVK-002 is a preserva...

9/20/2019
BreakingDiagnosticOphthalmicRetinal
Canon Xephilio Optical Coherence Tomography Device Gets FDA 510(k) Clearance

Canon’s Xephilio OCT-A1 Optical Coherence Tomography device has been cleared for sale in the US, the company announced Sept. 17. The Xephilio OCT-A1 has a scanning speed of 70 thousand A-scans per ...

9/20/2019
BreakingOphthalmicPharma
Vertical Pharmaceuticals Files NDA for Candidate for Droopy Eyelid

Vertical Pharmaceuticals announced Sept. 18 that it has submitted a new drug application to the US FDA for RVL-1201, its oxymetazoline hydrochloride ophthalmic solution for acquired blepharoptosis,...

9/20/2019
BreakingGene TherapyOphthalmicRetinal
Wize Pharma Reaches Licensing Deal for Ophthalmic Nonviral Gene Therapy Technology

Wize Pharma, of Israel, has entered into an exclusive license agreement with US-based Copernicus Therapeutics for rights to develop and commercialize products based on Copernicus’ nonviral gene the...

Past News Stories

9/13/2019
NewsletterOrthopedic
SI-BONE’s iFuse Receives Coverage

SI-BONE announced Sept. 3 that its minimally invasive sacroiliac joint fusion device, iFuse, received coverage from Wellmark Blue Cross Blue Shield. This system covers over 1.5 million members acro...

9/13/2019
NewsletterOrthopedic
JAAOS Article Reports Laser Spine Surgery Poses More Risks Than Benefits

The Journal of the American Academy of Orthopaedic Surgeons (JAAOS) published an article Sept. 1 by Kris Radcliff, MD, et al., stating that laser spine surgery is not supported by clinical data. Th...

9/13/2019
NewsletterOrthopedic
WishBone Signs Agreement to Distribute OsteoCrete

WishBone Medical signed a private-label distribution agreement with Bone Solutions for OsteoCrete, a resorbable, magnesium-based bone void filler, the company announced Aug. 15. This agreement give...

9/13/2019
NewsletterOrthopedic
CARLSMED Merges With Precisive Surgical

Medical technology company CARLSMED announced July 17 that it completed a merger with Precisive Surgical, a spine imaging company. The end goal of this deal is to create a complete, personalized su...

9/12/2019
CataractOphthalmicPress ReleaseSingle-Use
Cataract Surgery Products Continue to be the Main Single-Use Surgical Device Sales Driver

The world’s aging population--leading to steady growth in cataract surgeries--and rising concerns over cross-contamination are key factors that will drive healthy growth in the single-use ophthalmi...

9/13/2019
BreakingGene TherapyOphthalmicRetinal
Cigna to Cover Full Price of Luxturna, Zolgensma Gene Therapies in the US

Cigna Health will cover the price of gene therapies Luxturna and Zolgensma in the US, ensuring patients have no out-of-pocket costs, the health service company announced Sept. 5. To do so, Cigna ha...

9/13/2019
BreakingCataractOphthalmicSurgical
Keranova Raises $26.5 Million in Second Round for Cataract Surgery Technology

France-based Keranova announced Sept. 10 that it raised $26.5 million (€24 million) in a second round of financing. The company is developing a system designed to combine several steps of cataract ...

9/13/2019
BreakingCornealDeviceOphthalmic
Biotissue Expands Sales Force Following $82.25M Financing by Parent TissueTech

Biotissue announced Sept. 11 that it is expanding its sales force for its cryopreserved amniotic membrane products for ophthalmic use through funding raised by parent TissueTech. TissueTech reporte...

9/13/2019
BreakingOphthalmicPharmaRetinal
Novartis Announces EU Approval of Lucentis for Preterm Infants with Retinopathy of Prematurity

The Swiss company Novartis announced Sept. 6 the European approval of Lucentis (ranibizumab) for preterm infants with retinopathy of prematurity (ROP), making it the first and only licensed drug tr...

9/13/2019
BreakingCornealOphthalmicPharma
Kowa Submits IND to US FDA to Study its Glanatec Rho Kinase Inhibitor for Corneal Endothelial Diseases

The Japanese company Kowa announced Sept. 3 that it had submitted an investigational new drug (IND) application to the US FDA to begin a Phase II study for its ripasudil hydrochloride hydrate Rho k...

9/13/2019
BreakingOphthalmicPharmaRetinal
Allergan and Molecular Partners Announce Acceptance of Applications in US, EU for Abicipar Pegol in Patients with Wet AMD

Allergan and Molecular Partners announced Sept. 9 that the US FDA had accepted a biologics license application and the European Medicines Agency (EMA) had validated a marketing authorization applic...

9/13/2019
BreakingGlaucomaOphthalmicPharma
Ocuphire Completes Enrollment in Phase II Trials of Nyxol Drops for Glaucoma

Ocuphire Pharma, of Farmington Hills, Michigan, announced Sept. 4 that it had successfully enrolled 39 glaucoma patients at five US sites from late May to August 2019 for the ORION-1 Phase IIb tria...

Want to Read the Full Article?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email: info@market-scope.com

©2019 Market Scope, LLC. All Rights reserved.